Is it possible to use riamilovir to prevent infection and treat COVID-19?
Routine clinical use of riamilovir in COVID-19 is not recommended. The use of riamilovir is possible in clinical trials.
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Izdatelstvo OKI
2020-10-01
|
| Col·lecció: | Качественная клиническая практика |
| Matèries: | |
| Accés en línia: | https://www.clinvest.ru/jour/article/view/518 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|